The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for ALPCO Diagnostics sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
ALPCO Diagnostics (ALPCO) is a life science company that imports and distributes immunoassay based products. The company’s products include the MAX 9k automated system, GeneProof epstein-barr virus (EBV) PCR kit, ELISA kits, IL-6 ELISA, IgE ELISA, cortisol ELISA, hepatitis A virus antigen ELISA, among others. It markets its products under STELLUX brand. The company’s products are used for therapeutic areas such as antibodies and antigens, bone metabolism, allergy and infectious disease, endocrinology, diabetes and obesity, toxicology and neurobiology. It markets products through a network of distributors located across the world. ALPCO is headquartered in Salem, New Hampshire, the US.
The key metrics of ALPCO Diagnostics related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As ALPCO Diagnostics is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as ALPCO Diagnostics.
For a detailed understanding of the performance of ALPCO Diagnostics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
